Effective stakeholder engagement: design and implementation of a clinical trial (SWOG S1415CD) to improve cancer care
![Stream VELVET BASSMENT RADIOSHOW WITH HURRICANE MEESH VOL.34 by Tropical Velvet | Listen online for free on SoundCloud Stream VELVET BASSMENT RADIOSHOW WITH HURRICANE MEESH VOL.34 by Tropical Velvet | Listen online for free on SoundCloud](https://i1.sndcdn.com/artworks-SeyzbcJ0iovmzeZX-zmsWog-t500x500.jpg)
Stream VELVET BASSMENT RADIOSHOW WITH HURRICANE MEESH VOL.34 by Tropical Velvet | Listen online for free on SoundCloud
![Five-year follow-up of SWOG S0816: limitations and values of a PET-adapted approach with stage III/IV Hodgkin lymphoma. - Abstract - Europe PMC Five-year follow-up of SWOG S0816: limitations and values of a PET-adapted approach with stage III/IV Hodgkin lymphoma. - Abstract - Europe PMC](https://europepmc.org/articles/PMC6788007/bin/bloodBLD2019000719absf1.jpg)
Five-year follow-up of SWOG S0816: limitations and values of a PET-adapted approach with stage III/IV Hodgkin lymphoma. - Abstract - Europe PMC
The SWOG Difference | We support SWOG - what makes a SWOG cancer clinical trial unique? | By The Hope Foundation | Facebook
![Combining precision radiotherapy with molecular targeting and immunomodulatory agents: a guideline by the American Society for Radiation Oncology - The Lancet Oncology Combining precision radiotherapy with molecular targeting and immunomodulatory agents: a guideline by the American Society for Radiation Oncology - The Lancet Oncology](https://www.thelancet.com/cms/attachment/80b30ace-34eb-4d0d-ad33-68795ebf051a/gr1_lrg.jpg)
Combining precision radiotherapy with molecular targeting and immunomodulatory agents: a guideline by the American Society for Radiation Oncology - The Lancet Oncology
![Current Standards and Ongoing Controversies in the Management of Locally Advanced Non-Small Cell Lung Cancer - ScienceDirect Current Standards and Ongoing Controversies in the Management of Locally Advanced Non-Small Cell Lung Cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0093775405000849-gr1.gif)
Current Standards and Ongoing Controversies in the Management of Locally Advanced Non-Small Cell Lung Cancer - ScienceDirect
![Paxman Limb Cryocompression System to be used in SWOG Cancer Research Network Study Testing for Prevention of Chemotherapy Induced Peripheral Neuropathy Paxman Limb Cryocompression System to be used in SWOG Cancer Research Network Study Testing for Prevention of Chemotherapy Induced Peripheral Neuropathy](https://www.accesswire.com/users/newswire/images/726247/2%20systems%20with%202%20wraps%20-%20new%20copy%203%20(6).jpg)
Paxman Limb Cryocompression System to be used in SWOG Cancer Research Network Study Testing for Prevention of Chemotherapy Induced Peripheral Neuropathy
Retreatment of Patients Surviving Cancer-Free 2 or More Years After Initial Treatment of Small Cell Lung Cancer
![nCoup, Inc.: SWOG-nCartes Pilot Collaboration Shows Significant Expected Time Savings for Study Data Entry at SCT Annual Meeting nCoup, Inc.: SWOG-nCartes Pilot Collaboration Shows Significant Expected Time Savings for Study Data Entry at SCT Annual Meeting](https://mma.prnewswire.com/media/1089343/nCoup_Inc_Logo.jpg?p=twitter)
nCoup, Inc.: SWOG-nCartes Pilot Collaboration Shows Significant Expected Time Savings for Study Data Entry at SCT Annual Meeting
The SWOG Difference | We support SWOG - what makes a SWOG cancer clinical trial unique? | By The Hope Foundation | Facebook
Extranodal presentation in limited-stage diffuse large Bcell lymphoma as a prognostic marker in three SWOG trials S0014, S0313 and S1001 | Haematologica
![IJMS | Free Full-Text | Shaping the Future of Immunotherapy Targets and Biomarkers in Melanoma and Non-Melanoma Cutaneous Cancers IJMS | Free Full-Text | Shaping the Future of Immunotherapy Targets and Biomarkers in Melanoma and Non-Melanoma Cutaneous Cancers](https://pub.mdpi-res.com/ijms/ijms-24-01294/article_deploy/html/images/ijms-24-01294-g001.png?1673262055)